ahlam1399
08-29-2016, 05:22 PM
Mylan to launch generic EpiPen at half the price of original
(Reuters) - Mylan NV said it would launch the first generic version of its allergy auto-injector EpiPen at half the price of the branded product, the drugmaker's second step in less than a week to counter a wave of criticism over the product's high price.http://feeds.feedburner.com/~ff/reuters/topNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/topNews?a=9G27iZblNMY:cuXemIfMGkc:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/topNews?i=9G27iZblNMY:cuXemIfMGkc:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/topNews?a=9G27iZblNMY:cuXemIfMGkc:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/topNews?i=9G27iZblNMY:cuXemIfMGkc:-BTjWOF_DHI (http://feeds.reuters.com/~ff/reuters/topNews?a=9G27iZblNMY:cuXemIfMGkc:-BTjWOF_DHI)
http://feeds.feedburner.com/~r/reuters/topNews/~4/9G27iZblNMY
(Reuters) - Mylan NV said it would launch the first generic version of its allergy auto-injector EpiPen at half the price of the branded product, the drugmaker's second step in less than a week to counter a wave of criticism over the product's high price.http://feeds.feedburner.com/~ff/reuters/topNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/topNews?a=9G27iZblNMY:cuXemIfMGkc:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/topNews?i=9G27iZblNMY:cuXemIfMGkc:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/topNews?a=9G27iZblNMY:cuXemIfMGkc:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/topNews?i=9G27iZblNMY:cuXemIfMGkc:-BTjWOF_DHI (http://feeds.reuters.com/~ff/reuters/topNews?a=9G27iZblNMY:cuXemIfMGkc:-BTjWOF_DHI)
http://feeds.feedburner.com/~r/reuters/topNews/~4/9G27iZblNMY